
    
      Randomized, controlled, multicenter study.The intervention group was monitored with Flo
      Trac/Vigileo and optimized with fluid challenges, dobutamine and blood transfusion, if
      necessary, to maintain a IDO² ≥600ml/min/m² during 8h. The control group was treated
      according to the discretion of the attending physician.
    
  